Idaptiq Trials Inc.
About Idaptiq Trials Inc.
Idaptiq is a company of software developers and clinical research leaders using AI to modernize clinical trial execution through end-to-end biostatistics automation. The platform automates and connects core biostatistics deliverables required for FDA and other regulatory submissions, including SAP, SDTM, ADaM, and TLFs. It reduces manual labor hours and accelerates clinical trial timelines while ensuring patient data never enters the cloud or passes through an LLM. The company maintains study-level, customer-level, and system-level security with isolated tenants and encryption.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $2.79M in private placement with undisclosed investors.
- Platform automates SAP, SDTM, ADaM, and TLFs for regulatory submissions.
- Patient data remains isolated and never enters the cloud or LLMs.
- Led by CEO Sandy Ferber Brine and CTO Nate Fox with headquarters in Boulder, CO.
- Employs 7 people and focuses on reducing manual labor in clinical trials.
Ask StreetZero about Idaptiq Trials Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account